Amy Pooler
VP, Head of Research, SANGAMO THERAPEUTICS, INC.
Companies
- SANGAMO THERAPEUTICS, INCVP, Head of Research Nov 28, 2023 to Aug 27, 20241
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- SANGAMO THERAPEUTICS, INC SGMOQ193,923 shares2$27.3K at $0.14Aug 25, 2024
As of each latest filing. The line shows shares held over time.
Recent filings
- Aug 25, 2024Shares withheld for tax 493 shares at $0.86 of SANGAMO THERAPEUTICS, INC2
- Aug 24, 2024Shares withheld for tax 703 shares at $0.86 of SANGAMO THERAPEUTICS, INC2
- May 25, 2024Shares withheld for tax 493 shares at $0.60 of SANGAMO THERAPEUTICS, INC3
- May 24, 2024Shares withheld for tax 702 shares at $0.60 of SANGAMO THERAPEUTICS, INC3
- Feb 25, 2024Shares withheld for tax 2,459 shares at $1.13 of SANGAMO THERAPEUTICS, INC4
- Feb 24, 2024Shares withheld for tax 2,209 shares at $1.13 of SANGAMO THERAPEUTICS, INC4
- Jan 22, 2024Granted 150,000 shares of SANGAMO THERAPEUTICS, INC5
- Nov 25, 2023Shares withheld for tax 490 shares at $0.38 of SANGAMO THERAPEUTICS, INC6
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARForm 4 filed May 29, 2024
- 4SEC EDGARForm 4 filed Feb 27, 2024
- 5SEC EDGARForm 4 filed Jan 24, 2024
- 6SEC EDGARForm 4 filed Nov 28, 2023